From April 1, 2024 to June 30, 2024, the company has repurchased 8,426,500 shares, representing 0.44% for CNY 31.33 million. With this, the company has completed the repurchase of 45,659,040 shares, representing 2.37% for CNY 196.2 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 CNY | -0.89% |
|
+0.60% | -24.55% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.55% | 88Cr | |
+13.97% | 498.97Cr | |
-32.08% | 360.87Cr | |
-1.63% | 309.74Cr | |
-24.62% | 264.21Cr | |
-9.82% | 231.64Cr | |
+38.87% | 184.7Cr | |
+38.84% | 143.09Cr | |
-15.47% | 138.93Cr | |
+40.95% | 137.23Cr |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.